Dr Agarwal's Eye Hospital Ltd
BSE:526783
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 622.95
5 535.7002
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DRAGARWQ stock under the Base Case scenario is 1 925.4273 INR. Compared to the current market price of 4 974.2998 INR, Dr Agarwal's Eye Hospital Ltd is Overvalued by 61%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dr Agarwal's Eye Hospital Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DRAGARWQ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Dr Agarwal's Eye Hospital Ltd
Balance Sheet Decomposition
Dr Agarwal's Eye Hospital Ltd
Current Assets | 598.3m |
Cash & Short-Term Investments | 357m |
Receivables | 129.3m |
Other Current Assets | 112m |
Non-Current Assets | 4.4B |
PP&E | 4.1B |
Intangibles | 8m |
Other Non-Current Assets | 228.6m |
Current Liabilities | 807.7m |
Accounts Payable | 318.4m |
Other Current Liabilities | 489.3m |
Non-Current Liabilities | 2.6B |
Long-Term Debt | 2.5B |
Other Non-Current Liabilities | 97.9m |
Earnings Waterfall
Dr Agarwal's Eye Hospital Ltd
Revenue
|
3.4B
INR
|
Cost of Revenue
|
-761.6m
INR
|
Gross Profit
|
2.7B
INR
|
Operating Expenses
|
-2B
INR
|
Operating Income
|
699.4m
INR
|
Other Expenses
|
-210.1m
INR
|
Net Income
|
489.3m
INR
|
Free Cash Flow Analysis
Dr Agarwal's Eye Hospital Ltd
INR | |
Free Cash Flow | INR |
DRAGARWQ Profitability Score
Profitability Due Diligence
Dr Agarwal's Eye Hospital Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Dr Agarwal's Eye Hospital Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
DRAGARWQ Solvency Score
Solvency Due Diligence
Dr Agarwal's Eye Hospital Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Dr Agarwal's Eye Hospital Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DRAGARWQ Price Targets Summary
Dr Agarwal's Eye Hospital Ltd
Dividends
Current shareholder yield for DRAGARWQ is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. The company is headquartered in Chennai, Tamil Nadu. The firm provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti vegf, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and paediatric ophthalmology. The company also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The firm provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh and Andaman.
Contact
IPO
Employees
Officers
The intrinsic value of one DRAGARWQ stock under the Base Case scenario is 1 925.4273 INR.
Compared to the current market price of 4 974.2998 INR, Dr Agarwal's Eye Hospital Ltd is Overvalued by 61%.